Lantheus Holdings sold 35,769 shares of Perspective Therapeutics at $3.12 per share on Sep. 1, 2026. The transaction matters because Lantheus remained invested in Perspective Therapeutics, owning 11,563,425 shares after the sale, while its stated status was a 10% owner.

Key Highlights

  • The transaction took place on Sep. 1, 2026.
  • Lantheus Holdings owned 11,563,425 Perspective Therapeutics shares after the sale.
  • The transaction was recorded under sale code S.

Lantheus Holdings, Inc. (NASDAQ: LNTH) sold 35,769 shares of Perspective Therapeutics, Inc. at $3.12 per share. Lantheus Holdings is identified as a 10% owner of Perspective Therapeutics.

Perspective Therapeutics Shares Sold at $3.12

The transaction date was Sep. 1, 2026. The shares involved in the sale were shares of Perspective Therapeutics. The transaction was recorded under sale code S. The sale price was $3.12 per share. The reported transaction involved 35,769 shares, and the filing concerns Perspective Therapeutics shares rather than Lantheus Holdings’ own stock.

Post-Sale Perspective Therapeutics Position

Following the transaction, Lantheus Holdings owned 11,563,425 Perspective Therapeutics shares. The filing reports that Lantheus Holdings owned Perspective Therapeutics shares following the sale.